SANUWAVE Health, Inc. (ticker: SNWV) is an NASDAQ-listed clinical biotech company. DredgeCap's structured extraction of SNWV's SEC filings surfaces 12 active risk signals, including 11 late-filing signals, and 1 auditor-change signal. SNWV reported $9.62M in revenue and -$1.44M for the period ending 2026-03-31, with operating cash flow of $397K. Cash and equivalents stood at $10.78M (up 26.8% year-over-year). Total assets of $37.10M exceed total liabilities of $35.26M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
SNWV Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for SANUWAVE Health, Inc. (SNWV) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.